|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||-0.03|
|PE ratio (TTM)||N/A|
|Earnings date||06 Mar 2023 - 10 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
AnaptysBio ( NASDAQ:ANAB ) Third Quarter 2022 Results Key Financial Results Net loss: US$33.5m (loss widened by 403...
AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -151.06% and 92.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...